What is the share price of Ambuja Cements Ltd (AMBUJACEM) today?
The share price of AMBUJACEM as on 24th April 2025 is ₹572. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Ambuja Cements Ltd (AMBUJACEM) share?
The past returns of Ambuja Cements Ltd (AMBUJACEM) share are- Past 1 week: 1.70%
- Past 1 month: 10.89%
- Past 3 months: 3.66%
- Past 6 months: 2.34%
- Past 1 year: -11.24%
- Past 3 years: 52.86%
- Past 5 years: 240.58%
What are the peers or stocks similar to Ambuja Cements Ltd (AMBUJACEM)?
The peers or stocks similar to Ambuja Cements Ltd (AMBUJACEM) include:What is the dividend yield % of Ambuja Cements Ltd (AMBUJACEM) share?
The current dividend yield of Ambuja Cements Ltd (AMBUJACEM) is 0.31.What is the market cap of Ambuja Cements Ltd (AMBUJACEM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ambuja Cements Ltd (AMBUJACEM) is ₹141469.50 Cr as of 24th April 2025.What is the 52 week high and low of Ambuja Cements Ltd (AMBUJACEM) share?
The 52-week high of Ambuja Cements Ltd (AMBUJACEM) is ₹706.95 and the 52-week low is ₹453.05.What is the PE and PB ratio of Ambuja Cements Ltd (AMBUJACEM) stock?
The P/E (price-to-earnings) ratio of Ambuja Cements Ltd (AMBUJACEM) is 39.55. The P/B (price-to-book) ratio is 2.78.Which sector does Ambuja Cements Ltd (AMBUJACEM) belong to?
Ambuja Cements Ltd (AMBUJACEM) belongs to the Materials sector & Cement sub-sector.How to buy Ambuja Cements Ltd (AMBUJACEM) shares?
You can directly buy Ambuja Cements Ltd (AMBUJACEM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Ambuja Cements Ltd
AMBUJACEM Share Price
AMBUJACEM Share Price Chart
How to use scorecard? Learn more
AMBUJACEM Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
33.16 | 2.78 | 0.31% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
29.95 | 3.41 | 1.39% |
AMBUJACEM Analyst Ratings & Forecast
Detailed Forecast from 37 analysts
Price Upside
Earnings Growth
Rev. Growth
AMBUJACEM Company Profile
Ambuja Cements Limited is a cement manufacturing company. The Company manufactures Portland Pozollana cement (PPC).
Investor Presentation
View olderAMBUJACEM Similar Stocks (Peers)
Compare with peersAMBUJACEM Sentiment Analysis
AMBUJACEM Stock Summary · February 2025
The company is poised for significant growth, targeting a cement production capacity of 140 million tons by FY '28, supported by strategic acquisitions and investments in renewable energy. Despite facing operational challenges, including lower realizations and rising costs, management remains optimistic about improving efficiency through digital transformation and cost reduction initiatives. The commitment to sustainability, with a goal of achieving net zero emissions by 2050, aligns with market trends and enhances the company's competitive edge. While the current pricing environment in southern markets poses challenges, the focus on premium products and effective logistics management is expected to bolster profitability. Overall, a solid financial position, characterized by a nil debt status and substantial cash reserves, underpins the company's strategic ambitions.
Key Points on Ambujacem Stock
AMBUJACEM Stock Growth Drivers
6Expansion of Capacity and Infrastructure
The company has made significant strides in expanding its cement production capacity, with plans to
Financial Performance and Cost Management
The company reported strong financial results, with consolidated quarterly revenue reaching INR 9,329 crores and
AMBUJACEM Stock Challenges
5Operational Performance Weakness
Ambuja Cements Ltd. has reported a significant weakness in its operational performance, with an adjusted
Challenges from Newly Acquired Entities
The consolidation of newly acquired entities, Sanghi and Penna, has presented challenges as they are
AMBUJACEM Forecasts
Price
Revenue
Earnings
AMBUJACEM Share Price Forecast
All values in ₹
All values in ₹
AMBUJACEM Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
AMBUJACEM Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
AMBUJACEM
Income
Balance Sheet
Cash Flow
AMBUJACEM Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 20,572.93 | 23,944.07 | 26,424.91 | 27,704.26 | 24,980.20 | 29,338.13 | 31,448.03 | 39,702.76 | 34,560.51 | 36,588.15 | ||||||||||
Raw Materials | 16,951.17 | 19,751.11 | 22,181.93 | 22,506.56 | 19,686.61 | 22,875.51 | 27,259.62 | 5,230.77 | 4,898.79 | 28,404.60 | ||||||||||
Power & Fuel Cost | 11,761.90 | 8,109.31 | ||||||||||||||||||
Employee Cost | 1,856.53 | 1,352.79 | ||||||||||||||||||
Selling & Administrative Expenses | 11,200.69 | 9,291.03 | ||||||||||||||||||
Operating & Other expenses | 4,083.81 | 3,108.21 | ||||||||||||||||||
EBITDA | 3,621.76 | 4,192.96 | 4,242.98 | 5,197.70 | 5,293.59 | 6,462.62 | 4,188.41 | 5,569.06 | 7,800.38 | 8,183.55 | ||||||||||
Depreciation/Amortization | 1,460.93 | 1,219.45 | 1,153.94 | 1,152.52 | 1,161.78 | 1,152.49 | 1,292.34 | 1,644.67 | 1,623.38 | 2,145.05 | ||||||||||
PBIT | 2,160.83 | 2,973.51 | 3,089.04 | 4,045.18 | 4,131.81 | 5,310.13 | 2,896.07 | 3,924.39 | 6,177.00 | 6,038.50 | ||||||||||
Interest & Other Items | 152.99 | 205.78 | 170.50 | 169.87 | 140.22 | 145.66 | 155.47 | 194.90 | 276.38 | 294.56 | ||||||||||
PBT | 2,007.84 | 2,767.73 | 2,918.54 | 3,875.31 | 3,991.59 | 5,164.47 | 2,740.60 | 3,729.49 | 5,900.62 | 5,743.94 | ||||||||||
Taxes & Other Items | 573.77 | 1,251.37 | 741.14 | 1,780.31 | 1,626.15 | 2,384.09 | 802.14 | 1,146.09 | 2,323.83 | 1,477.63 | ||||||||||
Net Income | 1,434.07 | 1,516.36 | 2,177.40 | 2,095.00 | 2,365.44 | 2,780.38 | 1,938.46 | 2,583.40 | 3,576.79 | 4,266.31 | ||||||||||
EPS | 5.57 | 7.64 | 10.97 | 10.55 | 11.91 | 14.00 | 9.76 | 13.01 | 17.10 | 19.41 | ||||||||||
DPS | — | — | — | — | — | — | — | 2.50 | 2.00 | 2.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.19 | 0.12 | 0.10 |
AMBUJACEM Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Investor Presentation
AMBUJACEM Past Performance & Peer Comparison
MaterialsCement
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Ambuja Cements Ltd | 39.55 | 2.78 | 0.31% |
UltraTech Cement Ltd | 50.17 | 5.83 | 0.57% |
Grasim Industries Ltd | 32.40 | 1.31 | 0.36% |
Shree Cement Ltd | 45.73 | 5.28 | 0.35% |
AMBUJACEM Stock Price Comparison
Compare AMBUJACEM with any stock or ETFAMBUJACEM Shareholdings
AMBUJACEM Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
AMBUJACEM Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
AMBUJACEM Shareholding Pattern
AMBUJACEM Shareholding History
Mutual Funds Invested in AMBUJACEM
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Ambuja Cements Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.4316% | Percentage of the fund’s portfolio invested in the stock 1.62% | Change in the portfolio weight of the stock over the last 3 months 0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 13/94 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.3940% | Percentage of the fund’s portfolio invested in the stock 1.13% | Change in the portfolio weight of the stock over the last 3 months 0.19% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 25/102 (+5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.2968% | Percentage of the fund’s portfolio invested in the stock 0.85% | Change in the portfolio weight of the stock over the last 3 months 0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 36/61 (+5) |
Compare 3-month MF holding change on Screener
smallcases containing AMBUJACEM stock
Looks like this stock is not in any smallcase yet.
AMBUJACEM Events
AMBUJACEM Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
AMBUJACEM Upcoming Dividends
No upcoming dividends are available
AMBUJACEM Past Dividends
Cash Dividend
Ex DateEx DateJun 14, 2024
Dividend/Share
₹2.00
Ex DateEx Date
Jun 14, 2024
Cash Dividend
Ex DateEx DateJul 7, 2023
Dividend/Share
₹2.50
Ex DateEx Date
Jul 7, 2023
Cash Dividend
Ex DateEx DateMar 30, 2022
Dividend/Share
₹6.30
Ex DateEx Date
Mar 30, 2022
Cash Dividend
Ex DateEx DateMar 19, 2021
Dividend/Share
₹1.00
Ex DateEx Date
Mar 19, 2021
Cash Dividend
Ex DateEx DateNov 5, 2020
Dividend/Share
₹17.00
Ex DateEx Date
Nov 5, 2020
AMBUJACEM Stock News & Opinions
Ambuja Cements announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 2 May 2025.Powered by Capital Market - Live
The company's board has appointed Rakesh Tiwary as the chief financial officer (CFO) of the company, effective from 1 April 2024. Rakesh Tiwary is a qualified chartered accountant, cost accountant, company secretary, and MBA with around 25 years of experience. Prior to joining the Adani Group, Tiwary worked with various reputed companies like Indian Oil, Reliance Industries, and JSW Steel. Rakesh joined the Adani Group in February 2016. From 2016 to 2022, Rakesh served as the CFO of Mundra Solar Photovoltaic (Adani Solar) and Adani Electricity Mumbai. In April 2022, Rakesh transitioned to the role of Head of Financial Management and Control for the Airports Business and later became the CFO of the Airports Business. Rakesh has over two decades of experience in spearheading a wide spectrum of accounts and finance. His expertise lies in the finance, accounting, and commercial functions of business; fundraising management; working capital assessment; credit control; taxation; and audit. The company's board of directors appointed Ajay Kapur as a whole-time director and chief executive officer (WTD and CEO) of the company from 16 September 2022 to 30 November 2025. He has been elevated, reappointed, and re-designated as managing director of the company (key managerial personnel) for 2 years, effective from 1 April 2025. Ajay Kapur possesses over 30 years of expertise in the cement, construction, power, and heavy metals sectors. Ajay holds an MBA from the K.J. Somaiya Institute of Management and a degree in economics. Additionally, he is an alumnus of the Wharton School of the University of Pennsylvania. Meanwhile, the company's board of directors appointed Vinod Bahety as whole-time director (WTD) and Chief Executive Officer (CEO), effective from 1 April 2025. His cessation as CFO will be effective from the close of business hours on 31 March 2025. Vinod Bahety has more than 25 years of corporate experience in various leadership positions in the manufacturing and finance industries. Prior to joining as the CFO of the cement business, he served as the group head for mergers & acquisitions at the Adani Group. Vinod played a crucial role in several major M&A mandates for the group. During his tenure in the banking industry, he successfully led some of the largest mandates in infrastructure project financing, contributing significantly to nation-building. He holds qualifications as a Chartered Accountant (CA) and a Cost and Works Accountant (CWA). Ambuja Cements is a major cement-producing company in India. The principal activity of the company is to manufacture and market cement and clinker for both domestic and export markets. The cement major's consolidated net profit zoomed 140.21% to Rs 2,620.09 crore in Q3 FY25 as against Rs 1,090.73 crore recorded in Q3 FY24. Revenue from operations rose 4.50% YoY to Rs 8,415.31 crore in the quarter ended 31 December 2024. Shares of Ambuja Cements shed 0.40% to Rs540.90 on the BSE.Powered by Capital Market - Live
The Board of Ambuja Cements at its meeting held on 28 March 2025 has approved the following: Appointment of Vinod Bahety (DIN: 09192400) as Additional Director and Wholetime Director and Chief Executive Officer (Key Managerial Personnel) of the Company for a term of three (3) years with effect from 1 April 2025; Appointment of Rakesh Tiwary as Chief Financial Officer (Key Managerial Personnel) of the Company with effect from 1 April 2025; Cessation of Vinod Bahety as Chief Financial Officer of the Company effective from closure of the business hours on 31 March 2025; Appointment of Praveen Garg (DIN: 00208604) as an Additional Director (Non Executive and Independent) on the Board of the Company for a term of three (3) consecutive years with effect from 1 April 2025. Powered by Capital Market - Live
Revenue from operations rose 4.50% YoY to Rs 8,415.31 crore in the quarter ended 31 December 2024. Profit before tax stood at Rs 2,336.07 crore in Q3 FY25, up 61.14% as against Rs 1,449.70 crore in posted Q3 FY24. Ambuja Cements' sales volume (cement and clinker) stood at 16.5 million tons during the third quarter of FY25, registering a growth of 17% on a YoY basis. In Q3 FY25, operating EBITDA declined 1.15% YoY to Rs 1,712 crore while EBITDA margin reduced to 18.4% as against 21.3% recorded in the similar quarter previous fiscal. EBITDA PMT de-grew 15.26% to Rs 1,038 in the December 2024 quarter as against Rs 1,225 crore recorded in Q3 of the previous year. The company's net worth increased by Rs 2,619 crore during the quarter, reaching a total of Rs 62,535 crore. It remains debt-free and continues to maintain its Crisil AAA (stable) and Crisil A1+ ratings. The cash & cash equivalent stood at Rs 8,755 crore, enabling accelerated growth in the future. The cement maker said that the higher volume along with improved operational parameters resulted in growth in all business parameters. On the outlook front, Ambuja Cements said, 'improved consumption demand in housing and infrastructure segments and increased government spending are poised to reverse the tepid 1.5-2% cement demand growth during H1 FY'25. This demand is expected to grow by 4-5% in FY'25, further supported by the pro-infra and housing Budget 2025. Ambuja Cements is well-positioned to benefit from these trends. The anticipated rebound in demand, supported by government initiatives, is likely to enhance cement sector performance in the coming quarters. Ambuja Cements will continue to grow at a faster speed than the industry.' Ajay Kapur, whole-time director & CEO, Ambuja Cements, stated, 'We are pleased to report a quarter of sustainable performance, aligned with our growth plan. With a focus on innovation, digitisation, customer satisfaction, and ESG, our vision drives our expansion into new geographies. Our strategic acquisitions have significantly increased our capacity and market presence. This will be dovetailed with our ongoing expansion projects, delivering exceptional value for our stakeholders and propelling us towards achieving over 104 MTPA capacity by Q4 FY'25 and 118 MTPA by FY 26.' Ambuja Cements is a major cement producing company in India. The principal activity of the company is to manufacture and market cement and clinker for both domestic and export markets. The stock tumbled 3.78% to end trade at Rs 522.20 on the BSE. Powered by Capital Market - Live
Net profit of Ambuja Cements rose 156.64% to Rs 2115.33 crore in the quarter ended December 2024 as against Rs 824.25 crore during the previous quarter ended December 2023. Sales rose 14.76% to Rs 9328.56 crore in the quarter ended December 2024 as against Rs 8128.80 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales9328.568128.80 15 OPM %18.3521.31 - PBDT3000.051865.82 61 PBT2336.071449.70 61 NP2115.33824.25 157 Powered by Capital Market - Live
Ambuja Cements will hold a meeting of the Board of Directors of the Company on 29 January 2025.Powered by Capital Market - Live
Sanghi Industries operates a large, fully integrated cement plant in Kutch, Gujarat, which includes a 6.6 MMTPA clinker plant, a 6.1 MMTPA cement plant, and a 130 MW captive power plant, among other facilities. Both Sanghi and Ambuja Cements are part of the Adani Group. Its revenue was Rs 821.35 crore in FY24.. Penna Cement Industries operates four integrated plants in Andhra Pradesh and Telangana, along with a grinding unit in Maharashtra, with an operational capacity of 10 MTPA. Additionally, two plants with a capacity of 2 MTPA each are under construction in Krishnapatnam and Jodhpur, expected to be completed within the next 8-12 months. Penna Cement also owns five bulk cement terminals in Kolkata, Gopalpur, Karaikal, Kochi, and Colombo (Sri Lanka). Ambuja Cements holds 58.08% in Sanghi Industries and 67.53% in Penna Cement Industries. The scheme will enable the Ambuja Cements to integrate the Sanghi Industries and Penna Cement Industries' operations, leading to more efficient and economical business management. This includes better resource utilization, reduced overheads, cost savings, economies of scale, elimination of duplicated efforts, and streamlined compliance requirements through amalgamation. For every 100 equity shares of SIL with a face value of Rs 10 each, Ambuja Cements will issue 12 equity shares with a face value of Rs 2 each, to eligible shareholders of SIL. The said scheme of amalgamation will be expected to be completed within 9-12 months. Ajay Kapur, CEO, Cement Business, Adani Group, said, 'This merger aims to make our company more competitive and efficient, ultimately enhancing shareholder value. Enhanced working capital management and internal funds will support the growth of our business operations. Unified cash flow management will pool resources for faster expansion and cost savings in administration and governance, thereby simplifying compliance requirements. This advancement through a larger entity will increase market competitiveness and deliver greater value to our shareholders.' Ambuja Cements is a major cement producing company in India. The principal activity of the company is to manufacture and market cement and clinker for both domestic and export markets. The cement major's consolidated net profit slipped 52.1% to Rs 472.89 crore in Q2 FY25 as against Rs 987.24 crore recorded in Q2 FY24. However, revenue from operations rose 1.24% YoY to Rs 7,516.11 crore in the quarter ended 30 September 2024. Shares of Ambuja Cements fell by 1.11% to Rs 564.60. Meanwhile, Sanghi Industries saw a sharp decline of 11.15%, with its shares dropping to Rs 68.34 on the BSE.Powered by Capital Market - Live
The key equity indices traded with minor losses in early trade. The Nifty slipped below the 24,350 mark. Auto, PSU Bank and Realty shares declined while Pharma, IT and FMCG shares advanced. At 09:29 IST, the barometer index, the S&P BSE Sensex was down 101.17 points or 0.13% to 80,583.28. The Nifty 50 index lost 19.05 points or 0.08% to 24,316.95. In the broader market, the S&P BSE Mid-Cap index declined 0.26% and the S&P BSE Small-Cap index fell 0.22%. The market breadth was negative. On the BSE, 1,472 shares rose and 1,553 shares fell. A total of 110 shares were unchanged. Foreign portfolio investors (FPIs) sold shares worth Rs 6,409.86 crore, while domestic institutional investors (DIIs) were net buyers to the tune of Rs 2,706.48 crore in the Indian equity market on 13 December 2024, provisional data showed. Stocks in Spotlight: Ambuja Cements added 0.28%. The company has announced scheme of arrangement of its subsidiaries Sanghi Industries (SIL) and Penna Cement Industries (PCI). For every 100 equity shares of SIL with a face value of Rs 10 each, Ambuja Cements will issue 12 equity shares with a face value of Rs 2 each, to eligible shareholders of SIL. Piramal Enterprises shed 0.89%. The company's administrative committee will hold a meeting on Friday to consider and approve the public issuance of non convertible debentures. Alkem Laboratories rose 1.23%. The company along with its arm Enzene Biosciences entered into a share subscription and shareholders' agreement with Sunsure Solarpark Twenty-Two and Sunsure Energy for equity investment in Sunsure solarpark. Numbers to Track: The yield on India's 10-year benchmark federal paper shed 0.05% to 6.866 as compared with previous close 6.870. In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 84.9200, compared with its close of 84.9125 during the previous trading session. MCX Gold futures for the 5 February 2024 settlement slipped 0.03% to Rs 76,845. The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, was down 0.02% to 106.93. The United States 10-year bond yield gained 0.16% to 4.392. In the commodities market, Brent crude for February 2024 settlement added 02 cents, or 0.03% to $73.21 a barrel. Global Markets: Most Asian shares rose on Wednesday, shrugging off modest declines on Wall Street as investors awaited the Federal Reserve's final interest rate decision of the year. While a 25-basis-point rate cut is widely anticipated, the market is keenly focused on the Fed's outlook for next year, given the potential impact of proposed policies that could reignite inflationary pressures. Japan's trade balance unexpectedly improved in November, supported by stronger-than-expected exports driven by increased demand from the U.S. and China and a weaker yen. The trade deficit narrowed to 117.6 billion yen ($770 million). US indices retreated on Tuesday as investors exercised caution ahead of the rate decision, with the tech sector experiencing a slight pullback from recent gains. The S&P 500 fell 0.4% to 6050.61 points, the NASDAQ Composite lost 0.3% to 20,108.30 points, and the Dow Jones Industrial Average closed 0.6% lower at 43,449.90 points. NVIDIA Corporation dropped 1.2%, while Alphabet fell 0.5%. Pfizer rose 4.6% after confirming that its 2025 profit expectations remain largely unchanged. Meanwhile, data showed US retail sales rose by 0.7% in November, exceeding forecasts. This robust figure suggests the economy remains strong and consumer spending remains healthy, despite challenges like inflation and high interest rates. This strength is underpinned by a solid job market and stable household finances. Powered by Capital Market - Live
Securities in F&O Ban: Bandhan Bank, Chambal Fertilizers, Granules India, Hindustan Copper, Manappuram Finance, National Aluminum, RBL Bank, PVR Inox shares are banned from F&O trading on 18 December 2024. New Listing: One Mobikwik Systems will make debut on bourses today. The IPO was subscribed 119.38 times. The issue was open between 11th December and 13th December 2024. The IPO's price band was between Rs 265 and 279 per share. Sai Life Sciences shares will list on stock market today. The IPO was subscribed 10.26 times. The issue opened between 11th December and 13 December 2024. The price band of the IPO is fixed at Rs 522'549 per share. Vishal Mega Mart will make debut on bourses today. The IPO was subscribed 27.28 times. The issue was opened on 11th December and 13th December 2024. The price band of the IPO was fixed between Rs 74 and 78 per share. Stocks to watch: Ambuja Cements announced scheme of arrangement of its subsidiaries Sanghi Industries (SIL) and Penna Cement Industries (PCI). For every 100 equity shares of SIL with a face value of Rs 10 each, Ambuja Cements will issue 12 equity shares with a face value of Rs 2 each, to eligible shareholders of SIL. Piramal Enterprises' administrative committee will hold a meeting on Friday to consider and approve the public issuance of non convertible debentures. Alkem Laboratories along with its arm Enzene Biosciences entered into a share subscription and shareholders' agreement with Sunsure Solarpark Twenty-Two and Sunsure Energy for equity investment in Sunsure solarpark. Aurobindo Pharma's wholly owned subsidiary, Apitoria Pharma's active-pharmaceutical ingredient (API) manufacturing plant in Telangana received two observations from US Food and Drug Administration (USFDA). Jindal Saw entered into an agreement with ReNew Green Energy Solutions to acquire shareholding up to 31.2% stake in ReNew Green MHH One. Suyog Telematics' board will consider raising funds through equity or any other equity‐linked or convertible securities from various modes.Powered by Capital Market - Live
Ambuja Cements announced separate Schemes of Arrangement of its subsidiaries Sanghi Industries (SIL) and Penna Cement Industries (PCIL). The proposed Schemes inter alia provide for the Amalgamation of SIL and PCIL with Ambuja Cement. SIL has a clinker capacity of 6.6 MTPA, cement capacity of 6.1 MTPA, and limestone reserves of ~1 billion tonnes. SIL's Sanghipuram plant is India's largest single-location cement and clinker unit by capacity, with a captive jetty and captive power plant. Penna has four integrated plants in Andhra Pradesh and Telangana, along with a grinding unit in Maharashtra. It has an operational capacity of 10 MTPA. Additionally, two plants, with a capacity of 2 MTPA each, are under construction in Krishnapatnam and Jodhpur, expected to be completed within next 8-12 months. It also has five bulk cement terminals at Kolkata, Gopalpur, Karaikal, Kochi, and Colombo (Sri Lanka). Ambuja Cements will issue 12 equity shares of the face value of Rs. 2/- each for every 100 equity shares of SIL of face value Rs. 10/- each as recommended by the valuers and accepted by the Board and thereby, the eligible shareholders of SIL will become the shareholders of Ambuja Cements. These transactions will be effected with requisite approvals from related stakeholders and authorities, anticipated to be completed within 9-12 months' time. Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 4.52%, vs industry avg of 9.52%
Over the last 5 years, market share decreased from 11.84% to 8.83%
Over the last 5 years, net income has grown at a yearly rate of 11.29%, vs industry avg of 15.68%